MOUNTAIN VIEW, Calif.,
Oct. 21, 2016 /PRNewswire/
-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of
medication and supply management solutions and analytics software
for healthcare facilities, will hold a conference call
Thursday, October 27, 2016, to
discuss the Company's third Quarter 2016 financial results.
What:
|
Omnicell Third
Quarter 2016 earnings conference call and webcast
|
When:
|
October 27, 2016,
1:30 p.m. PT
|
Who:
|
Randall Lipps,
chairman, president and chief executive officer
|
|
Peter Kuipers, chief
financial officer
|
Where:
|
The conference call
can be monitored by dialing 1-800-696-5518 within the
U.S.
|
|
or 1-706-758-4883 for
all other locations. The Conference ID # is 4139562.
|
|
The webcast can be
accessed at: http://ir.omnicell.com/events.cfm.
|
|
|
How:
|
Link to the Omnicell
website 15 minutes prior to the call to download necessary audio
software.
|
Replay:
|
Available starting at
4:30 p.m. PT on October 27, 2016 through 11:59 p.m. PT
on
|
|
December 8, 2016.
Dial 1-855-859-2056 within the U.S. and 1-404-537-3406 for all
other locations, Conference ID # 4139562.
|
About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create
safer and more efficient ways to manage medications and supplies
across all care settings. As a leader in medication and supply
dispensing automation, central pharmacy automation, IV robotics,
analytics software, and medication adherence and packaging
systems, Omnicell is focused on improving care across the entire
healthcare continuum—from the acute care hospital setting, to
post-acute skilled nursing and long-term care facilities, to the
patient's home.
Over 4,000 customers worldwide use Omnicell automation and
analytics solutions to increase operational efficiency, reduce
medication errors, deliver actionable intelligence and improve
patient safety. The recent acquisition of Aesynt adds distinct
capabilities, particularly in central pharmacy and IV robotics,
creating the broadest medication management product portfolio in
the industry.
The Omnicell SureMed solution provides innovative medication
adherence packaging to help reduce costly hospital readmissions.
These medication adherence solutions are used by over 17,000
institutional and retail pharmacies in North America and the United
Kingdom. These pharmacies are served via the Company's sales
channels and our solutions enable them to
maintain high accuracy and quality standards in medication
dispensing and administration while optimizing productivity and
controlling costs.
For more information about Omnicell, Inc. please visit
www.omnicell.com.
OMCL-E
Logo -
http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/omnicell-to-release-third-quarter-2016-earnings-results-on-october-27th-300349376.html
SOURCE Omnicell, Inc.